Cargando…
Durability of Protection Post–Primary COVID-19 Vaccination in the United States
The durability of immune responses after COVID-19 vaccination will drive long-term vaccine effectiveness across settings and may differ by vaccine type. To determine durability of protection of COVID-19 vaccines (BNT162b2, mRNA-1273, and Ad26.COV2.S) following primary vaccination in the United State...
Autores principales: | Zheutlin, Amanda, Ott, Miles, Sun, Ran, Zemlianskaia, Natalia, Meyer, Craig S., Rubel, Meagan, Hayden, Jennifer, Neri, Breno, Kamath, Tripthi, Khan, Najat, Schneeweiss, Sebastian, Sarsour, Khaled |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505933/ https://www.ncbi.nlm.nih.gov/pubmed/36146536 http://dx.doi.org/10.3390/vaccines10091458 |
Ejemplares similares
-
2659. Substantially Elevated Influenza Risk in Vaccinated Immunocompromised Adults and High-Risk Patients Relative to All Vaccinated
por: Zemlianskaia, Natalia, et al.
Publicado: (2023) -
Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge
por: Polinski, Jennifer M., et al.
Publicado: (2022) -
515. Evolution of Treatment Patterns for Patients Hospitalized with COVID-19 in the United States
por: Zalocusky, Kelly, et al.
Publicado: (2021) -
Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study
por: Kim, Seoyoung C., et al.
Publicado: (2017) -
Evaluation of Erlotinib in Advanced Non-Small Cell Lung Cancer: Impact on the Budget of a U.S. Health Insurance Plan
por: Ramsey, Scott D., et al.
Publicado: (2006)